Salud financiera de hoja de balance de Dynavax Technologies
Salud financiera controles de criterios 5/6
Dynavax Technologies tiene un patrimonio de los accionistas total de $618.5M y una deuda total de $223.0M, lo que sitúa su ratio deuda-patrimonio en 36.1%. Sus activos y pasivos totales son $986.6M y $368.1M respectivamente.
Información clave
36.1%
Ratio deuda-patrimonio
US$222.98m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$723.54m |
| Patrimonio | US$618.48m |
| Total pasivo | US$368.09m |
| Activos totales | US$986.57m |
Actualizaciones recientes sobre salud financiera
Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06
These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Recent updates
Lacklustre Performance Is Driving Dynavax Technologies Corporation's (NASDAQ:DVAX) Low P/S
May 22Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain
May 10Dynavax: Holding Firm Despite Its Missing Cash Cow
Mar 23Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06Dynavax Technologies Corporation's (NASDAQ:DVAX) Business And Shares Still Trailing The Industry
Jan 31These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02Improved Earnings Required Before Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Find Their Feet
Jun 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Clover, Dynavax COVID-19 vaccine gets EU GMP certificate
Sep 20Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12The Alphavaxers: Dynavax And Novavax, 2 Quarters On
Aug 22Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats
Aug 04Are Investors Undervaluing Dynavax Technologies Corporation (NASDAQ:DVAX) By 41%?
Jun 03Dynavax: Evolving Endemic Situation Adds To Its Risk
May 23Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
May 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Dynavax Technologies: Full Speed Ahead
Mar 01Here's Why Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt Responsibly
Jan 28Dynavax: A Coronavirus Growth Story
Jan 17Is Dynavax Technologies Corporation (NASDAQ:DVAX) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 18The Momentum Investor: Spotlight On Dynavax Technologies
Oct 25Dynavax And TLR Biology: Long-Delayed But Outstanding Success
Oct 16These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Reasonably Well
Oct 02Upgrade: Analysts Just Made A Meaningful Increase To Their Dynavax Technologies Corporation (NASDAQ:DVAX) Forecasts
Aug 10Dynavax: Earnings This Year Ought To Surprise To The Upside
Aug 01Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($851.3M) de DVAX superan a sus pasivos a corto plazo ($56.0M).
Pasivo a largo plazo: Los activos a corto plazo de DVAX ($851.3M) superan a sus pasivos a largo plazo ($312.1M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: DVAX tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de DVAX ha pasado de 407% a 36.1% en los últimos 5 años.
Cobertura de la deuda: La deuda de DVAX está bien cubierta por el flujo de caja operativo (25.2%).
Cobertura de intereses: Datos insuficientes para determinar si los pagos de intereses de DVAX sobre su deuda están bien cubiertos por el EBIT.